Telix Pharmaceuticals Ltd (TLX) Insider Trading

Name: Telix Pharmaceuticals Ltd (TLX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 14, 2026): Smith Darren Charlton (Group Chief Financial Officer): Purchase of 2,071 shares, $20.0K.

Get alerted when insiders trade TLX

Email address

Loading company data...

Beta

Loading company details...

Beta